首页> 美国卫生研究院文献>Journal of Gastrointestinal Oncology >Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy combined with two-stage hepatectomy for multiple and bilobar desmoplastic small round cell tumor liver metastases
【2h】

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy combined with two-stage hepatectomy for multiple and bilobar desmoplastic small round cell tumor liver metastases

机译:细胞减少手术和高温腹膜内化疗联合两阶段肝切除术治疗多发性和双叶性增生性小圆形细胞瘤肝转移

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Desmoplastic small round cell tumor (DSRCT) is a rare mesenchymal tumor usually affecting young patients. Local dissemination is common, and liver is the most common site for extraperitoneal metastases. Multimodal management has been shown to be the most effective treatment. Some authors consider liver metastases especially bi-lobar disease as a contraindication for surgical resection. We present a case of a DSRCT with bi-lobar metastases in an adult patient who underwent multi-modal management along with hepatectomy. A 51-year-old man was found to have a large intraperitoneal mass with bi-lobar liver metastases during work up for new onset reflux and abdominal pain. Biopsy confirmed it as DSRCT. The patient was treated with multi-modal therapy including cytoreductive surgery (CRS), hyperthermic intraperitoneal chemotherapy (HIPEC), two-stage hepatectomy (TSHP) combined with (90Y) Yittrium-90 radioembolization of the right hepatic lobe and systemic chemotherapy. The patient had a right-sided pleural empyema one month after the surgery for which he required right-sided video-assisted thoracoscopy and decortication. He remains disease free at 2 years follow-up. DSRCT with bi-lobar liver metastases are best managed with multimodal therapy. TSHP seems to be a feasible and safe option in selected cases, with a potentially good outcome.
机译:增生性小圆形细胞肿瘤(DSRCT)是一种罕见的间质肿瘤,通常会影响年轻患者。局部扩散是常见的,肝脏是腹膜外转移的最常见部位。多模式管理已被证明是最有效的治疗方法。一些作者认为肝脏转移,尤其是双叶疾病是手术切除的禁忌症。我们介绍了一名成年患者的DSRCT发生双叶转移的情况,该患者接受了肝切除术的多模式管理。发现一名51岁的男子在工作中腹膜内肿块较大,并伴有双叶肝转移,新发反流和腹痛。活检证实为DSRCT。该患者接受了多种模式的治疗,包括细胞减灭术(CRS),高温腹膜内化疗(HIPEC),两阶段肝切除术(TSHP)结合右侧的( 90 Y)Yittrium-90放射栓塞术肝叶和全身化疗。该患者在手术后一个月出现了右侧胸膜积脓,为此他需要进行右侧电视胸腔镜检查和剥脱术。在2年的随访中,他仍然没有疾病。带有双叶肝转移的DSRCT最好通过多模式疗法来治疗。在某些情况下,TSHP似乎是一种可行且安全的选择,可能会产生良好的结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号